These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 28494969

  • 21. Populations of in silico myocytes and tissues reveal synergy of multiatrial-predominant K+ -current block in atrial fibrillation.
    Ni H, Fogli Iseppe A, Giles WR, Narayan SM, Zhang H, Edwards AG, Morotti S, Grandi E.
    Br J Pharmacol; 2020 Oct; 177(19):4497-4515. PubMed ID: 32667679
    [Abstract] [Full Text] [Related]

  • 22. Human electrophysiological and pharmacological properties of XEN-D0101: a novel atrial-selective Kv1.5/IKur inhibitor.
    Ford J, Milnes J, Wettwer E, Christ T, Rogers M, Sutton K, Madge D, Virag L, Jost N, Horvath Z, Matschke K, Varro A, Ravens U.
    J Cardiovasc Pharmacol; 2013 May; 61(5):408-15. PubMed ID: 23364608
    [Abstract] [Full Text] [Related]

  • 23. Vernakalant does not alter early repolarization or contractility in normal and electrically remodelled atria.
    van Hunnik A, Nasrallah H, Lau DH, Kuiper M, Verheule S, Schotten U.
    Europace; 2018 Jan 01; 20(1):140-148. PubMed ID: 28449044
    [Abstract] [Full Text] [Related]

  • 24. Inhibition of IKr potentiates development of atrial-selective INa block leading to effective suppression of atrial fibrillation.
    Burashnikov A, Belardinelli L, Antzelevitch C.
    Heart Rhythm; 2015 Apr 01; 12(4):836-44. PubMed ID: 25546810
    [Abstract] [Full Text] [Related]

  • 25. Electrical and structural remodeling contribute to atrial fibrillation in type 2 diabetic db/db mice.
    Bohne LJ, Jansen HJ, Daniel I, Dorey TW, Moghtadaei M, Belke DD, Ezeani M, Rose RA.
    Heart Rhythm; 2021 Jan 01; 18(1):118-129. PubMed ID: 32911049
    [Abstract] [Full Text] [Related]

  • 26. Inhibitory effects of hesperetin on Kv1.5 potassium channels stably expressed in HEK 293 cells and ultra-rapid delayed rectifier K(+) current in human atrial myocytes.
    Wang H, Wang HF, Wang C, Chen YF, Ma R, Xiang JZ, Du XL, Tang Q.
    Eur J Pharmacol; 2016 Oct 15; 789():98-108. PubMed ID: 27397430
    [Abstract] [Full Text] [Related]

  • 27. Human induced pluripotent stem cell-derived atrial cardiomyocytes recapitulate contribution of the slowly activating delayed rectifier currents IKs to repolarization in the human atrium.
    Sönmez MI, Goldack S, Nurkkala E, Schulz C, Klampe B, Schulze T, Hansen A, Eschenhagen T, Koivumäki J, Christ T.
    Europace; 2024 Jun 03; 26(6):. PubMed ID: 38788213
    [Abstract] [Full Text] [Related]

  • 28. The new antiarrhythmic drug vernakalant: ex vivo study of human atrial tissue from sinus rhythm and chronic atrial fibrillation.
    Wettwer E, Christ T, Endig S, Rozmaritsa N, Matschke K, Lynch JJ, Pourrier M, Gibson JK, Fedida D, Knaut M, Ravens U.
    Cardiovasc Res; 2013 Apr 01; 98(1):145-54. PubMed ID: 23341576
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Analysis of electropharmacological effects of AVE0118 on the atria of chronic atrioventricular block dogs: characterization of anti-atrial fibrillatory action by atrial repolarization-delaying agent.
    Kambayashi R, Hagiwara-Nagasawa M, Ichikawa T, Goto A, Chiba K, Nunoi Y, Izumi-Nakaseko H, Matsumoto A, Takahara A, Sugiyama A.
    Heart Vessels; 2020 Sep 01; 35(9):1316-1322. PubMed ID: 32346771
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Kv1.5 is an important component of repolarizing K+ current in canine atrial myocytes.
    Fedida D, Eldstrom J, Hesketh JC, Lamorgese M, Castel L, Steele DF, Van Wagoner DR.
    Circ Res; 2003 Oct 17; 93(8):744-51. PubMed ID: 14500335
    [Abstract] [Full Text] [Related]

  • 39. Mechanisms of atrial fibrillation termination by rapidly unbinding Na+ channel blockers: insights from mathematical models and experimental correlates.
    Comtois P, Sakabe M, Vigmond EJ, Munoz M, Texier A, Shiroshita-Takeshita A, Nattel S.
    Am J Physiol Heart Circ Physiol; 2008 Oct 17; 295(4):H1489-504. PubMed ID: 18676686
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.